CHFR and neoplasm: Importantly, there was no association between CHFR expression and response to paclitaxel monotherapy as measured by relative tumor cross-sectional area 4 weeks after initiation of therapy relative to the same tumors prior to treatment (Figure 4D) or relative to untreated tumors at the same timepoint (Figure 4E).